Literature DB >> 3139565

Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity.

R T Horvat1, M J Parmely.   

Abstract

This study was performed to determine the effect of Pseudomonas aeruginosa on gamma interferon (IFN-gamma) production by antigen-stimulated human T-cell clones. Crude bacterial filtrates prepared from certain strains of P. aeruginosa inhibited IFN-gamma production by T cells and reduced the antiviral activity of preformed IFN-gamma. Bacterial filtrates prepared from mutant strains that did not produce the exoenzyme alkaline protease (AP) did not inhibit IFN-gamma activity. The inhibitory activity of bacterial filtrates was heat and trypsin sensitive and was neutralized by an antiserum to AP. Crystalline AP mimicked the effects of the bacterial filtrates, and an inactive filtrate from a protease-deficient mutant strain was reconstituted by the addition of AP. AP-treated recombinant IFN-gamma showed altered migration on Western blots (immunoblots) of polyacrylamide gels, and this modification correlated with a dose-dependent loss of antiviral activity. The ability of recombinant IFN-gamma to elevate the expression of Fc receptors on cells of the U-937 histiocytic cell line was also diminished by AP treatment. These results indicate that the Pseudomonas protease AP can inhibit the antiviral and immunomodulatory activities of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139565      PMCID: PMC259672          DOI: 10.1128/iai.56.11.2925-2932.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  A new ultrasensitive method for the determination of proteolytic activity.

Authors:  H Rinderknecht; M C Geokas; P Silverman; B J Haverback
Journal:  Clin Chim Acta       Date:  1968-08       Impact factor: 3.786

2.  Defective cellular immunity to gram-negative bacteria in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; P Chase; S H Polmar
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

3.  Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes.

Authors:  P M Guyre; P M Morganelli; R Miller
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

4.  PRODUCTION OF ELASTASE AND PROTEINASE BY PSEUDOMONAS AERUGINOSA.

Authors:  K MORIHARA
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

5.  Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage.

Authors:  A S Kreger; L D Gray
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

6.  Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.

Authors:  D E Woods; S J Cryz; R L Friedman; B H Iglewski
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  In vitro inhibition of lymphocyte proliferation by Pseudomonas aeruginosa phenazine pigments.

Authors:  R U Sorensen; J D Klinger; H A Cash; P A Chase; D G Dearborn
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

9.  Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.

Authors:  G H Wong; I Clark-Lewis; L McKimm-Breschkin; A W Harris; J W Schrader
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  In vitro response of human T cells to Pseudomonas aeruginosa.

Authors:  J M Porwoll; H M Gebel; G E Rodey; R B Markham
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

View more
  28 in total

Review 1.  The role of ATP-binding cassette transporters in bacterial pathogenicity.

Authors:  Victoria G Lewis; Miranda P Ween; Christopher A McDevitt
Journal:  Protoplasma       Date:  2012-01-13       Impact factor: 3.356

2.  Functional analysis of the Burkholderia cenocepacia ZmpA metalloprotease.

Authors:  C Kooi; C R Corbett; P A Sokol
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

Review 3.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 4.  Bacterial perturbation of cytokine networks.

Authors:  M Wilson; R Seymour; B Henderson
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 5.  The detrimental impact of extracellular bacterial proteases on wound healing.

Authors:  Sharon Lindsay; Angela Oates; Katie Bourdillon
Journal:  Int Wound J       Date:  2017-07-25       Impact factor: 3.315

Review 6.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

7.  Interaction of truncated human interferon gamma variants with the interferon gamma receptor: crucial importance of Arg-129.

Authors:  J Haelewyn; L Michiels; P Verhaert; M F Hoylaerts; R Witters; M De Ley
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

8.  Proteolytic inactivation of cytokines by Pseudomonas aeruginosa.

Authors:  M Parmely; A Gale; M Clabaugh; R Horvat; W W Zhou
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

9.  ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract.

Authors:  C E Blue; G K Paterson; A R Kerr; M Bergé; J P Claverys; T J Mitchell
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

10.  Purification and characterization of an immunogenic aminopeptidase of Brucella melitensis.

Authors:  Araceli Contreras-Rodriguez; Bernardo Ramirez-Zavala; Andrea Contreras; Gerhardt G Schurig; Nammalwar Sriranganathan; Ahide Lopez-Merino
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.